Tetralogy of Fallot Overview
Learn About Tetralogy of Fallot
- Tetralogy of Fallot
- Fallot tetralogy
- TOF
Brigham And Women's Hospital, Heart And Vascular Center
Dr. Anne Marie Valente is the co-director of the Pregnancy and Cardiovascular Disease Program at Brigham and Women’s Hospital and outpatient director of the Boston Adult Congenital Heart Disease & Pulmonary Hypertension Program. A cardiovascular medicine and adult congenital heart disease specialist, she is also an associate professor of medicine and pediatrics at Harvard Medical School. Dr. Valente is the director of the Adult Congenital Heart Disease and Pulmonary Hypertension Senior Fellowship Program at Harvard Medical School.She received her medical degree from University of Vermont College of Medicine. She completed a combined internal medicine/pediatrics residency, as well as pediatric cardiology, adult cardiovascular disease and cardiovascular magnetic resonance imaging fellowships at Duke University Medical Center. Dr. Valente is board certified in internal medicine, pediatrics, cardiovascular disease and pediatric cardiology.Dr. Valente’s clinical and research interests focus on adult congenital heart disease. Her current research examines heart failure complications in patients with repaired tetralogy of Fallot, a congenital heart defect. She has authored over 50 peer-reviewed publications, as well as numerous chapters and reviews about congenital heart disease imaging and the care of women with heart disease during pregnancy. She has received institutional recognition with the Lerner Research Award and the Watkins Discovery Award as well as research funding from the American Heart Association, the Children’s Miracle Network and the National Heart, Lung and Blood Institute.**The BACH program has been training clinicians in the care of adults with congenital heart disease for several decades. For more information about the Adult Congenital Heart Disease and Pulmonary Hypertension Senior Fellowship Program at Harvard Medical School, please visit the program website.**The BACH program is closely integrated in the Pregnancy and Cardiovascular Disease Program. This program involves a multi-disciplinary team dedicated to caring for women with heart disease during pregnancy. More information may be found here. Dr. Valente is rated as an Elite provider by MediFind in the treatment of Tetralogy of Fallot. Her top areas of expertise are Tetralogy of Fallot, Congenital Heart Disease (CHD), Ebstein's Anomaly, Cardiac Ablation, and Heart Transplant.
Brigham And Women's Hospital, Heart And Vascular Center
Dr. Michael J. Landzberg is the organizing founder and director of the Boston Adult Congenital Heart and Pulmonary Hypertension Group (BACH) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Landzberg received his medical degree from HMS. He completed a residency in internal medicine at Columbia-Presbyterian Medical Center and a fellowship in cardiovascular disease at BWH. Dr. Landzberg is board certified in internal medicine.Dr. Landzberg’s clinical interests include adult congenital heart disease and pulmonary hypertension. The author of more than 140 peer-reviewed publications, Dr. Landzberg’s research focuses on the management of congenital heart disease. Dr. Landzberg is rated as an Elite provider by MediFind in the treatment of Tetralogy of Fallot. His top areas of expertise are Congenital Heart Disease (CHD), Tetralogy of Fallot, Eisenmenger Syndrome, Heart Transplant, and Patent Foramen Ovale Repair.
Penn Heart And Vascular Center
Yuli Kim is a Cardiologist in Philadelphia, Pennsylvania. Dr. Kim is rated as an Elite provider by MediFind in the treatment of Tetralogy of Fallot. Her top areas of expertise are Congenital Heart Disease (CHD), Tetralogy of Fallot, Bicuspid Aortic Valve, Heart Transplant, and Thrombectomy. Dr. Kim is currently accepting new patients.
Summary: This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)
Summary: The goal of this clinical trial is to learn if a specific type of exercise training (high intensity interval training) can improve exercise capacity in people with a congenital heart defect that required the creation of a new connection between the right ventricle and pulmonary artery. This includes people with a truncus arteriosus, pulmonary atresia with a ventricular septal defect or severe tetr...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


